Manabu Morimoto Selected Research

Manabu Morimoto Research Topics

Disease

73	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2002
45	Neoplasms (Cancer) 05/2023 - 01/2002
26	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 12/2014
8	Necrosis 01/2022 - 01/2002
7	Adenocarcinoma 11/2023 - 09/2015
6	Neoplasm Metastasis (Metastasis) 06/2020 - 11/2002
4	Hypertension (High Blood Pressure) 04/2024 - 01/2019
4	Neutropenia 01/2022 - 05/2015
4	Chronic Hepatitis C 03/2021 - 01/2010
4	Fibrosis (Cirrhosis) 03/2021 - 07/2012
3	Ascites 08/2022 - 12/2020
3	Disease Progression 05/2022 - 04/2011
3	Anorexia 05/2022 - 01/2018
3	Thrombosis (Thrombus) 02/2021 - 01/2011
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 01/2014
3	Liver Diseases (Liver Disease) 01/2021 - 10/2015
3	Liver Neoplasms (Liver Cancer) 01/2020 - 02/2012
3	Residual Neoplasm 03/2012 - 03/2005
3	Focal Nodular Hyperplasia 05/2010 - 03/2007
3	Hemangioma (Angioma) 05/2010 - 03/2007
2	Leukopenia 04/2024 - 10/2020
2	Diarrhea 06/2023 - 01/2020
2	Sarcopenia 10/2022 - 01/2022
2	Thrombocytopenia (Thrombopenia) 05/2022 - 01/2021
2	Febrile Neutropenia 01/2022 - 01/2018
2	Gastric Outlet Obstruction 05/2021 - 11/2016
2	Infections 03/2021 - 01/2002
2	Anemia 10/2020 - 11/2016
1	Lymphatic Metastasis 08/2023
1	Proteinuria 05/2022
1	Sudden Death 05/2022
1	Fatigue 05/2022
1	Cachexia 01/2022
1	Thromboembolism 11/2021

Drug/Important Bio-Agent (IBA)

20	Sorafenib (BAY 43-9006)FDA Link 06/2023 - 04/2011
17	Contrast MediaIBA 10/2015 - 09/2002
16	Gemcitabine FDA Link 11/2023 - 01/2014
10	perfluorobutane (AI 700)IBA 10/2015 - 03/2008
8	lenvatinibIBA 04/2024 - 01/2020
6	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 11/2002
5	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 11/2002
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2021 - 03/2013
5	Epirubicin (Ellence)FDA LinkGeneric 06/2021 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2012
5	SonazoidIBA 07/2010 - 03/2008
4	atezolizumabIBA 03/2024 - 03/2022
4	Bevacizumab (Avastin)FDA Link 03/2024 - 03/2022
4	Leucovorin (Folinic Acid)FDA Link 11/2023 - 01/2018
4	Fluorouracil (Carac)FDA LinkGeneric 11/2023 - 01/2018
4	RamucirumabIBA 09/2021 - 01/2019
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024 - 01/2019
3	Therapeutic UsesIBA 10/2022 - 07/2003
3	130-nm albumin-bound paclitaxelIBA 10/2022 - 01/2020
3	folfirinoxIBA 09/2022 - 01/2018
3	BilirubinIBA 09/2021 - 01/2020
3	AlbuminsIBA 09/2021 - 01/2020
3	PolymersIBA 06/2021 - 01/2017
3	Serum AlbuminIBA 01/2020 - 02/2007
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2013
3	miriplatinIBA 02/2018 - 02/2010
3	PlatinumIBA 01/2018 - 12/2017
2	Alanine Transaminase (SGPT)IBA 04/2024 - 05/2022
2	cabozantinibIBA 05/2023 - 01/2021
2	Antiviral Agents (Antivirals)IBA 03/2021 - 12/2013
2	ARQ 197IBA 10/2020 - 05/2015
2	C-Reactive ProteinIBA 01/2020 - 02/2012
2	Fetal Proteins (Fetoprotein)IBA 01/2019 - 08/2012
2	Vitamin K FDA Link 05/2013 - 02/2007
2	GadoliniumIBA 03/2013 - 01/2012
2	Pentetic Acid (DTPA)FDA LinkGeneric 03/2013 - 01/2012
2	SuspensionsIBA 02/2010 - 03/2008
2	LipidsIBA 02/2010 - 03/2008
2	Palmitic Acid (Hexadecanoic Acid)IBA 03/2007 - 01/2003
2	Galactose (Galactopyranose)FDA LinkGeneric 03/2007 - 01/2003
2	Ethanol (Ethyl Alcohol)IBA 10/2005 - 09/2002
2	GelatinIBA 06/2005 - 10/2004
2	Iodized OilIBA 06/2005 - 10/2004
2	SHU 508 (Levovist)IBA 07/2003 - 09/2002
1	napabucasinIBA 06/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Eicosapentaenoic AcidIBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 11/2021
1	Blood Coagulation Factors (Coagulation Factor)IBA 11/2021
1	SofosbuvirIBA 03/2021

Therapy/Procedure

29	Therapeutics 02/2023 - 01/2002
19	Drug Therapy (Chemotherapy) 04/2024 - 09/2013
14	Radiofrequency Ablation 08/2014 - 01/2002
13	Adjuvant Chemotherapy 08/2023 - 12/2014
4	Microspheres (Microsphere) 06/2021 - 08/2015
3	High-Intensity Focused Ultrasound Ablation 12/2013 - 08/2010
3	Microbubbles 02/2010 - 03/2008
3	Electrodes (Electrode) 11/2002 - 01/2002
2	Pancreaticoduodenectomy 10/2016 - 05/2016
1	Intra-Arterial Infusions 04/2024
1	Aftercare (After-Treatment) 11/2023
1	Neoadjuvant Therapy 08/2023
1	Chemoradiotherapy 08/2023
1	Folfox protocol 02/2023
1	Molecular Targeted Therapy 01/2022
1	Stents 05/2021